Absci signals expanded clinical pipeline with ABS-101 in Phase I and ABS-201 targeting early 2026 trial Absci signals expanded clinical pipeline with ABS-101 in Phase I and ABS-201 targeting early 2026 trial Post ContentabsiRead More You might also be interested in reading Laurentian Bank of Canada declares CAD 0.47 dividend. May 14, 2025 In Mainstream ← Previous post Next post →